Accelrx Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACCELRX LABS, and what generic and branded alternatives to ACCELRX LABS drugs are available?
ACCELRX LABS has one approved drug.
Summary for Accelrx Labs
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Accelrx Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accelrx Labs | CARISOPRODOL | carisoprodol | TABLET;ORAL | 040576-001 | Jun 7, 2005 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
